Ticker
POAICompany Name
PREDICTIVE ONCOLOGY INCSector
HealthcareIndustry
Medical Instruments & SuppliesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -9.07M | -847.68% | $ 1.07M |
3/31/2025 | $ -10.19M | -756.83% | $ 1.35M |
12/31/2024 | $ -11.97M | -737.07% | $ 1.62M |
9/30/2024 | $ -13.69M | -992.67% | $ 1.38M |
6/30/2024 | $ -13.39M | -765.87% | $ 1.75M |
3/31/2024 | $ -14.12M | -720.31% | $ 1.96M |
12/31/2023 | $ -13.24M | -744.04% | $ 1.78M |
9/30/2023 | $ -17.51M | -968.25% | $ 1.81M |
6/30/2023 | $ -18.24M | -1177.25% | $ 1.55M |
3/31/2023 | $ -24.56M | -1716.64% | $ 1.43M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for PREDICTIVE ONCOLOGY INC is calculated as follows: EBITDA [ $ -27.03M ] / Revenues [ $ 1.31M ]
(=) EBITDA % [ -2069.8% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |